| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049663955 |
| P356 | DOI | 10.1054/BJOC.1999.1089 |
| P932 | PMC publication ID | 2374482 |
| P698 | PubMed publication ID | 10755399 |
| P5875 | ResearchGate publication ID | 232779608 |
| P50 | author | Mercedes Robledo | Q30362248 |
| Ana Osorio | Q43181086 | ||
| P2093 | author name string | F Lobo | |
| J Benítez | |||
| A Barroso | |||
| B Martínez | |||
| J M San Román | |||
| A Cebrián | |||
| P2860 | cites work | Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium | Q24671905 |
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history | Q28267644 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study | Q34385784 | ||
| BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. | Q35238541 | ||
| Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? | Q35238904 | ||
| Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. | Q36617510 | ||
| Familial breast cancer and its recognition in an oncology clinic | Q41636592 | ||
| Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families | Q42691997 | ||
| Population genetics of BRCA1 and BRCA2. | Q43109039 | ||
| Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. | Q43597405 | ||
| Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains | Q48068725 | ||
| Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population | Q59312609 | ||
| Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families | Q59539082 | ||
| Rapid detection of BRCA1 mutations by the protein truncation test | Q62978349 | ||
| BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer | Q73328358 | ||
| Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations | Q74082972 | ||
| BRCA1 and BRCA2: from molecular genetics to clinical medicine | Q74546101 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1266-70 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families | |
| P478 | volume | 82 |
| Q59539012 | A haplotype containing thep53polymorphisms Ins16bp and Arg72Pro modifies cancer risk inBRCA2mutation carriers |
| Q48229800 | Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects |
| Q44215482 | Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing |
| Q51525736 | BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. |
| Q46574954 | BRCA1 variants in a family study of African-American and Latina women |
| Q45326488 | BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients. |
| Q59274524 | BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families |
| Q34336498 | Breast feeding, parity and breast cancer subtypes in a Spanish cohort |
| Q59538992 | Classification of missense variants of unknown significance inBRCA1based on clinical and tumor information |
| Q59539040 | Clustering of cancer-related mutations in a subset ofBRCA1alleles: A study in the Spanish population |
| Q87646062 | Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing |
| Q42522379 | Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes |
| Q54488788 | Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. |
| Q34125091 | Family history and breast cancer hormone receptor status in a Spanish cohort |
| Q33368443 | Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. |
| Q33786876 | Functional characterization of Ape1 variants identified in the human population |
| Q43942751 | Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer |
| Q38120406 | Genetics of disc-related disorders: current findings and lessons from other complex diseases |
| Q37156098 | Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci |
| Q34123323 | High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients |
| Q42519156 | Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families |
| Q57240039 | Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer |
| Q38985438 | Male breast cancer. A report of 71 cases |
| Q37322992 | MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours |
| Q59539038 | No mutations in theXRCC2gene inBRCA1/2-negative high-risk breast cancer families |
| Q48085053 | Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives. |
| Q59539034 | Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations |
| Q34160157 | Pathogenesis of colorectal cancer |
| Q35443103 | Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics |
| Q54765466 | Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. |
| Q35830539 | Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer |
| Q50485878 | Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade. |
| Q37662302 | Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model |
| Q59539024 | The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population |
| Q36149597 | The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications |
| Q35355084 | The pathology of hereditary breast cancer |
| Q54415246 | Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors. |
| Q78389663 | [Molecular study of the BRCA1 and BRCA2 genes in 153 breast cancer families from Castilla and León (Spain): new nine unclassified variants identified] |
Search more.